Business Description
Duearity AB
ISIN : SE0015949482
Compare
Compare
Traded in other countries / regions
DEAR.Sweden9DS.Germany IPO Date
2021-05-11Description
Duearity AB is a medical technology company. It develops smallest and flexible products and services for tinnitus under the Tinearity brand.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | -1.07 | |||||
| Debt-to-Equity | -0.39 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -20.39 | |||||
| Beneish M-Score | -4.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -141.4 | |||||
| 3-Year EPS without NRI Growth Rate | -145.8 | |||||
| 3-Year FCF Growth Rate | -163.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 24.61 | |||||
| 14-Day RSI | 32.92 | |||||
| 6-1 Month Momentum % | -50.83 | |||||
| 12-1 Month Momentum % | -96.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.37 | |||||
| Quick Ratio | 0.09 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 324.75 | |||||
| Days Sales Outstanding | 64.53 | |||||
| Days Payable | 336.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.2 | |||||
| Shareholder Yield % | -262.67 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -114.95 | |||||
| Operating Margin % | -1436.77 | |||||
| Net Margin % | -1489.25 | |||||
| FCF Margin % | -1127.13 | |||||
| ROA % | -281.78 | |||||
| ROIC % | -274.68 | |||||
| 3-Year ROIIC % | -190.77 | |||||
| ROC (Joel Greenblatt) % | -1227.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.53 | |||||
| EV-to-EBIT | -0.23 | |||||
| EV-to-EBITDA | -0.23 | |||||
| EV-to-Revenue | 3.26 | |||||
| EV-to-FCF | -0.29 | |||||
| Earnings Yield (Greenblatt) % | -434.78 | |||||
| FCF Yield % | -818.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Duearity AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 2.241 | ||
| EPS (TTM) (kr) | -0.422 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.12 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 421.6 | ||
| 14-Day RSI | 32.92 | ||
| 14-Day ATR (kr) | 0.00017 | ||
| 20-Day SMA (kr) | 0.0154 | ||
| 12-1 Month Momentum % | -96.36 | ||
| 52-Week Range (kr) | 0.0135 - 0.794386 | ||
| Shares Outstanding (Mil) | 200.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Duearity AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Duearity AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Duearity AB Frequently Asked Questions
What is Duearity AB(OSTO:DEAR)'s stock price today?
The current price of OSTO:DEAR is kr0.02. The 52 week high of OSTO:DEAR is kr0.79 and 52 week low is kr0.01.
When is next earnings date of Duearity AB(OSTO:DEAR)?
The next earnings date of Duearity AB(OSTO:DEAR) is 2025-02-27.
Does Duearity AB(OSTO:DEAR) pay dividends? If so, how much?
Duearity AB(OSTO:DEAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers